Jason Harry has 30 years of commercial and academic experience in the medical device field. He is the founder and CEO of Lucidux, LLC, an early-stage company developing advanced visualization technologies for minimally invasive surgery. Previously, he was founder and CEO of Afferent Corporation, which focused on neurostimulation technologies to treat chronic dysfunction stemming from stroke, aging, and diabetes. Prior to founding Afferent, he was VP of Research Engineering at NMT Medical, Inc., Boston, MA, a company in the field of minimally invasive cardiovascular implants.
Jason has deep experience in start-up financing, including the process of winning and managing over $2 million in research funding from NIH SBIR and other programs.
He received his PhD from Harvard University, MS from MIT, and BS from Georgia Tech. He was on the engineering faculty of Brown University, where his research areas were functional neural stimulation and muscle mechanics.